CEO: Roger L. Hawley.

Revenue: $23.4 million for 2010; no revenue in 2009.

Net loss: $73.6 million for 2010; $45.9 million in 2009.

No. of local employees: 26.

Headquarters: San Diego.

Year founded: 2006.

Stock symbol and exchange: ZGNX on Nasdaq.

Company description: A pharmaceutical company that develops and commercializes products that treat central nervous system disorders and pain.

Key factors for success: The company uses a proprietary technology called DosePro for delivering injection drugs under the skin without a needle, and it develops new pharmaceutical products based on existing, already-proven medications.

Zogenix Inc...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to SDBJ.com archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $99